Natalizumab is an FDA-approved monoclonal antibody for treating multiple sclerosis and Crohn disease. Initially sanctioned in 2004 for multiple sclerosis treatment, its market presence faced a setback due to reported fatalities linked to progressive multifocal leukoencephalopathy. The FDA withdrew approval for natalizumab but later reinstated it in 2006, responding to advocacy from the multiple sclerosis community. When used judiciously alongside an advisory committee, this drug demonstrates efficacy in slowing symptom progression during flares and reducing relapse rates in individuals with relapsing-remitting multiple sclerosis. This activity discusses natalizumab’s indications, mechanism of action, administration methods, notable adverse effects, contraindications, monitoring protocols, and toxicity considerations. By assimilating this information, healthcare providers can navigate patient therapy toward optimal outcomes for those grappling with multiple sclerosis.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/25578
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.5 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.5 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.5 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, All Practice Areas (e.g. ethics), Critical Care Medicine, Gastroenterology, General Pediatrics, General Surgery, Hospital Medicine, Internal Medicine, Medical Toxicology, Non-Thoracic Surgery, Pediatric Critical Care Medicine, Pediatric Gastroenterology, Pediatric Neurology, Rheumatology